"We must change the awareness paradigm in order to reverse the course of this disease," said Steve Tang, CEO of the Bethlehem-based diagnostics company.
Brokerages expect OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) to announce ($0.14) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for OraSure Technologies’ earnings. The lowest EPS estimate is ($0.20) and the highest is ($0.07). OraSure Technologies reported earnings per share of ($0.02) in the same […]
Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) to announce $64.74 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for OraSure Technologies’ earnings, with the highest sales estimate coming in at $68.30 million and the lowest estimate coming in at $62.22 million. OraSure Technologies posted […]